VERA: Rega marang dodolan Vera Corp

Logo korporat perusahaan Vera Therapeutics Inc (VERA)

The P/S multiple, which stands at 189.30, reflects the revenue valuation dynamics of Vera Therapeutics, Inc. (VERA), which utilizes manufacturing outsourcing to maintain flexibility. Exclusive antibody rights and lobbyist support create a powerful defensive moat. Meanwhile, access to capital depends on drug trials, necessitating strict liquidity management amid high R&D expenditures.

Vera Pharma - Multiplikator P/S VERA (periode 07.11.2026 - 17.11.2026)

Rincian analitis perusahaan Vera Corp (VERA)

Ringkesan analitik perusahaan:Vera Pharma, VERA
Produk dadi Vera Pharma

The P/S ratio is calculated as the ratio of market capitalization to annual revenue, measuring the value of one dollar of sales within the share price. For Vera Therapeutics, Inc. (VERA), this metric reflects market expectations for future monopoly revenues following the completion of costly clinical trials, allowing the P/S multiple to distinguish justified business value growth from a speculative bubble.

Karo sapa Vera Therapeutics, Inc. saingan

argenx - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (biontech.de)|Abivax Corp (ABVX) - Rega marang dodolan|ADMA Corp - Multiplikator P/S|Rasio rega marang dodolan PTGX|Immunovant Inc (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols Biemat) - Multiplikator P/S|Multiplikator P/S Adaptive Biotechnologies Inc.|Rasio rega marang pendapatan Celldex Therapeutics (CLDX)|Koefisien rega marang pendapatan auriniapharma.com|Rasio rega marang pendapatan BioCryst Pharmaceuticals BCRX|Kapitalisasi marang volume dodolan DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - Multiplikator P/S|ABCL: Rasio rega marang pendapatan|Tourmaline Bio, Inc. (TRML) - Rasio rega marang pendapatan|Rega marang dodolan precigen.com (PGEN)|PHAR (pharming.com) - Multiplikator P/S|NKTR (Nektar Therapeutics Inc.) - Kapitalisasi marang volume dodolan|Multiplikator P/S UPB|ZBIO - Rega marang dodolan|Multiplikator P/S IMNM (immunome.com)|Gossamer Bio, Inc. - Rasio rega marang pendapatan|KalVista Pharmaceuticals, Inc. - Multiplikator P/S|SEPN (Septerna) - Rasio kapitalisasi marang pendapatan|Pieris Corp (PVLA) - Rasio rega marang pendapatan|SVRA - Koefisien rega marang pendapatan|RIGL (rigel.com) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ANAB (AnaptysBio, Inc.)|Multiplikator P/S ATXS|enGene Holdings Inc (ENGN) - Multiplikator rega marang pendapatan|Multiplikator P/S RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Rasio rega marang dodolan|ACRS: Kapitalisasi marang pendapatan|KYTX - Multiplikator P/S|TLSA: Multiplikator P/S|Kapitalisasi marang pendapatan Cabaletta Bio, Inc|Rasio rega marang pendapatan Ventyx Biosciences, Inc|THTX: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan AVTX (Avalo Therapeutics, Inc)|Kapitalisasi marang pendapatan Eledon Pharmaceuticals ELDN|Rasio rega marang pendapatan Agenus, Inc. AGEN|Multiplikator P/S Climb Bio Inc. CLYM|ZURA - Rasio rega marang pendapatan|Rasio rega marang dodolan ATYR|ADAG (Adagene Inc.) - Kapitalisasi marang pendapatan|ImageneBio Inc (IMA) - Multiplikator P/S|Rasio rega marang pendapatan Shattuck Therapeutics|Kapitalisasi marang pendapatan equilliumbio.com (EQ)|Multiplikator P/S CNTB|Koefisien rega marang pendapatan Immunic Therapeutics|Multiplikator P/S ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Rasio kapitalisasi marang pendapatan|CELU: Multiplikator P/S|INMB - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Barinthus Biotherapeutics plc|KZR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SABS|AKTX (Akari Therapeutics Plc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Rasio rega marang pendapatan|GOVX: Kapitalisasi marang pendapatan|edesabiotech.com (EDSA) - Kapitalisasi marang pendapatan|IBIO: Multiplikator P/S|CARM - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan XTLB|Kapitalisasi marang pendapatan boltbio.com (BOLT)|Rasio rega marang pendapatan HCW Biologics Inc (HCWB)|Multiplikator P/S Aptevo Therapeutics, Inc. (APVO)|Rasio rega marang pendapatan aimimmuno.com AIM|Rasio kapitalisasi pasar marang pendapatan ADTX|GRI Bio Corporation - Multiplikator P/S|XORTX Corp (XRTX) - Kapitalisasi marang pendapatan|HIND (Vyome Holdings Inc.) - Kapitalisasi marang pendapatan|revbiosciences.com (REVB) - Multiplikator P/S|INDP (Indaptus Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Scinai Immunotherapeutics Ltd (SCNI)|Rasio rega marang pendapatan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos Inc.)|Multiplikator P/S HOOKIPA HOOK|IGMS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iTeos)|OCEA: Multiplikator P/S|TCBP (TC BioPharm Ltd) - Rasio rega marang pendapatan|THRD (Third Harmonic Bio Inc) - Multiplikator P/S